相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Senescence and extracellular vesicles: novel partners in vascular amyloidosis
Meredith Whitehead et al.
AGING-US (2023)
Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression
Bing Bai et al.
NEURON (2020)
Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation
Erik C. B. Johnson et al.
NATURE MEDICINE (2020)
TMTpro reagents: a set of isobaric labeling mass tags enables simultaneous proteome-wide measurements across 16 samples
Jiaming Li et al.
NATURE METHODS (2020)
Shared proteomic effects of cerebral atherosclerosis and Alzheimer's disease on the human brain
Aliza P. Wingo et al.
NATURE NEUROSCIENCE (2020)
Identification of Conserved Proteomic Networks in Neurodegenerative Dementia
Vivek Swarup et al.
CELL REPORTS (2020)
Boosting to Amplify Signal with Isobaric Labeling (BASIL) Strategy for Comprehensive Quantitative Phosphoproteomic Characterization of Small Populations of Cells
Lian Yi et al.
ANALYTICAL CHEMISTRY (2019)
Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age
Aliza P. Wingo et al.
NATURE COMMUNICATIONS (2019)
Network Analysis of a Membrane-Enriched Brain Proteome across Stages of Alzheimer's Disease
Lenora Higginbotham et al.
PROTEOMES (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Comprehensive Single-Shot Proteomics with FAIMS on a Hybrid Orbitrap Mass Spectrometer
Alexander S. Hebert et al.
ANALYTICAL CHEMISTRY (2018)
Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach
Erika Bereczki et al.
BRAIN (2018)
Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry
Philipp Mertins et al.
NATURE PROTOCOLS (2018)
Alzheimer disease pathology and the cerebrospinal fluid proteome
Loic Dayon et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Global quantitative analysis of the human brain proteome in Alzheimer's and Parkinson's Disease
Lingyan Ping et al.
SCIENTIFIC DATA (2018)
Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease
Qi Zhang et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Biomarkers for Alzheimer's disease: current status and prospects for the future
K. Blennow et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease
Erik C. B. Johnson et al.
MOLECULAR NEURODEGENERATION (2018)
Effects of APOE Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease
Jingting Dai et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Deep Profiling of the Aggregated Proteome in Alzheimer's Disease: From Pathology to Disease Mechanisms
Brianna M. Lutz et al.
PROTEOMES (2018)
A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain
Mfon E. Umoh et al.
EMBO MOLECULAR MEDICINE (2018)
Alzheimer's disease: A matter of blood-brain barrier dysfunction?
Axel Montagne et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Mass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid β 1-42 in CSF for the Diagnosis of Alzheimer's Disease
Gwenael Pottiez et al.
JOURNAL OF PROTEOME RESEARCH (2017)
NPTX2 and cognitive dysfunction in Alzheimers Disease
Mei-Fang Xiao et al.
ELIFE (2017)
A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease
Nicholas T. Seyfried et al.
CELL SYSTEMS (2017)
Impact of multiple pathologies on the threshold for clinically overt dementia
Alifiya Kapasi et al.
ACTA NEUROPATHOLOGICA (2017)
Paraoxonase and atherosclerosis-related cardiovascular diseases
Dimitry A. Chistiakov et al.
BIOCHIMIE (2017)
Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease
Amy R. Nelson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
The Cellular Phase of Alzheimer's Disease
Bart De Strooper et al.
CELL (2016)
Accelerating Medicines Partnership: Alzheimer's Disease (AMP-AD) Knowledge Portal Aids Alzheimer's Drug Discovery through Open Data Sharing
Richard J. Hodes et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Soyon Hong et al.
SCIENCE (2016)
Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders
Neelroop N. Parikshak et al.
NATURE REVIEWS GENETICS (2015)
A Cellular Perspective on Brain Energy Metabolism and Functional Imaging
Pierre J. Magistretti et al.
NEURON (2015)
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
Ye Zhang et al.
JOURNAL OF NEUROSCIENCE (2014)
Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases
Manikandan Narayanan et al.
MOLECULAR SYSTEMS BIOLOGY (2014)
Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease
Michael B. Dinkins et al.
NEUROBIOLOGY OF AGING (2014)
Amyloid-beta isoform metabolism quantitation by stable isotope-labeled kinetics
Kwasi G. Mawuenyega et al.
ANALYTICAL BIOCHEMISTRY (2013)
GO-Elite: a flexible solution for pathway and ontology over-representation
Alexander C. Zambon et al.
BIOINFORMATICS (2012)
Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?
Shayne A. Bellingham et al.
FRONTIERS IN PHYSIOLOGY (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
SMOC1 Is Essential for Ocular and Limb Development in Humans and Mice
Ippei Okada et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Asymptomatic Alzheimer's Disease: A Prodrome or a State of Resilience?
I. Driscoll et al.
CURRENT ALZHEIMER RESEARCH (2011)
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
Annika Thorsell et al.
BRAIN RESEARCH (2010)
Osteopontin is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease and Its Levels Correlate with Cognitive Decline
Cristoforo Comi et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
The Angiogenic Growth Factor and Biomarker Midkine Is a Tumor-Shared Antigen
Jerome Kerzerho et al.
JOURNAL OF IMMUNOLOGY (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
Clinical proteomics of the cerebrospinal fluid: Towards the discovery off now biomarkers
Stephane Roche et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Alzheimer's disease β-amyloid peptides are released in association with exosomes
Lawrence Rajendran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Overlap between neurodegenerative disorders
RA Armstrong et al.
NEUROPATHOLOGY (2005)
Simultaneous measurement of β-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology
A Olsson et al.
CLINICAL CHEMISTRY (2005)
Toll-like receptors in innate immunity
K Takeda et al.
INTERNATIONAL IMMUNOLOGY (2005)
The endothelium and lipoproteins: Insights from recent cell biology and animal studies
DJ Rader et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2000)
分享论文
